Come up with a name for your new list and we'll add to it:
G1 Therapeutics raised a round of funding on September 30, 2011. Investors include
National Institutes of Health.
G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. The company is advancing a pipeline of potenti…